Dr. Surabhi Srivastava is trained as a molecular biologist in the areas of epigenetics and stem cell biology. In recent years she has been actively involved in genomics projects and guiding Bioinformatics teams in biological interpretation of the data. She is currently at the steering wheel for the Rockefeller Foundation’s Indian SARS-CoV-2 genome surveillance program led by CSIR-CCMB.
